In-vivo studies of targeted and localized cancer drug release from microporous poly-di-methyl-siloxane (PDMS) devices for the treatment of triple negative breast cancer
2024Scientific ReportsJournalOpen access
10.1038/s41598-023-50656-6Full text12 citations